https://www.zacks.com/stock/news/2245096/clorox-s-clx-ignite-strategy-to-evolve-portfolio-bodes-well?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2245096
Mar 22, 2024 - Clorox (CLX) benefits from pricing actions and cost-saving initiatives. The company is on track to streamline its operating model to improve efficiency.
zc:-6415486843342709958
0
https://www.zacks.com/stock/news/2244299/b-g-foods-bgs-innovation-pipeline-bodes-well-amid-high-costs?cid=CS-ZC-FT-analyst_blog|rank_focused-2244299
Mar 21, 2024 - B&G Foods (BGS) bolsters its product range with innovative seasoning blends and streamlines its portfolio for higher profitability despite facing challenges from increased SG&A expenses.
zc:4332061036771930526
0
https://www.zacks.com/stock/news/2242259/accenture-acn-to-post-q2-earnings-here-s-what-to-expect?cid=CS-ZC-FT-analyst_blog|earnings_preview-2242259
Mar 18, 2024 - Accenture's (ACN) second-quarter fiscal 2024 revenues and earnings are expected to have declined from the year-ago levels.
zc:-1361600092075050032
0
https://www.zacks.com/stock/news/2242105/is-post-holdings-post-stock-undervalued-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2242105
Mar 18, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
zc:-7025826060633157832
0
https://www.zacks.com/stock/news/2242143/are-consumer-staples-stocks-lagging-freshpet-frpt-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2242143
Mar 18, 2024 - Here is how Freshpet (FRPT) and Post Holdings (POST) have performed compared to their sector so far this year.
zc:-6616257442817906578
0
https://www.zacks.com/stock/news/2241559/stoneco-stne-to-post-q4-earnings-what-s-in-the-offing?cid=CS-ZC-FT-analyst_blog|earnings_preview-2241559
Mar 15, 2024 - StoneCo's (STNE) fourth-quarter 2023 performance will likely reflect strength in its financial services and software business.
zc:8239352456409447454
0
https://www.zacks.com/stock/news/2241487/h-world-group-htht-to-post-q4-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2241487
Mar 15, 2024 - H World Group's (HTHT) fourth-quarter 2023 top line is likely to benefit from the sustained recovery in both leisure and business travel demand.
zc:-5581896000780177249
0
https://www.zacks.com/stock/news/2240745/philip-morris-pm-advances-smoke-free-evolution-with-new-launch?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2240745
Mar 14, 2024 - Philip Morris (PM) unveils the IQOS ILUMA i to continue offering enhanced alternatives to consumers. Philip Morris is well-placed to become a majority smoke-free company.
zc:2107406939318522577
0
https://seekingalpha.com/article/4678082-deutsche-post-why-i-now-rate-it-a-hold-given-recent-performance?source=feed_all_articles
Mar 13, 2024 - Deutsche Post faces EBIT growth challenges due to economic uncertainty and shipping rates, prompting a downgrade from Buy to Hold. Read an analysis here.
0
sa:-2308286462993716564
0
https://www.zacks.com/stock/news/2240235/lexicon-lxrx-dips-on-post-hoc-analysis-data-on-sotagliflozin?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2240235
Mar 13, 2024 - New post hoc analysis of data from Lexicon's (LXRX) phase III study shows improvements in glycemic control when treated with sotagliflozin for type 1 diabetes and chronic kidney disease.
zc:-2088542816091824413
0